The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to InBios International for antigens. These antigens developed by InBios are unique in that they can be used for detection of specific pathogens. No other company has developed these antigens. CDC employs these materials for conducting diagnosis of human disease under specific scientific and regulatory framework. Employing other materials would require duplication of effort and delays in providing services to the public. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1).. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within three (3) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to William Brannen at [email protected] by 3:00 P.M. EST., January 12, 2017.

 

Bid Protests Not Available